Navigation Links
Avalon Pharmaceuticals to Present at the American Association for,Cancer Research 2007 Annual Meeting

e monosphospate dehydrogenase (IMPDH), an enzyme that is critical for cells to be able to synthesize guanosine triphosphate (GTP), a molecule required for DNA synthesis and cellular signaling. IMPDH is over expressed in some cancer cells, especially in the case of hematological malignancies. In laboratory experiments, AVN944 has been shown to inhibit IMPDH activity in cells, and suppress pools of GTP. Anticancer activities of IMPDH inhibitors correlate with sustained depletion of GTP pools both in cellular models and in human subjects. AVN944 appears to have a selective effect on cancer cells in that deprivation of GTP in normal cells results in a temporary slowing of cell growth, while GTP deprivation in cancer cells induces cell death, or apoptosis. Results from preclinical studies of AVN944 indicate that AVN944 inhibited the proliferation of lymphoid and myeloid cells, the principal cells involved in the most common types of human leukemias. In a single-dose, dose- escalation phase I clinical trial of AVN944 conducted in the United Kingdom in healthy volunteers, AVN944: (1) was well tolerated at all tested doses with no notable side effects; (2) demonstrated good pharmacokinetic properties; and (3) had a significant inhibitory effect on IMPDH enzyme activity. Avalon filed an IND with the FDA in August 2005 and initiated U.S. phase I clinical trials in January 2006 for the treatment of hematological cancers.

Avalon Pharmaceuticals is a biopharmaceutical company using its proprietary technology, AvalonRx(R), to discover and develop cancer therapeutics. Avalon has a lead product in Phase I clinical development (AVN944 - IMPDH inhibitor), as well as preclinical programs to discover inhibitors for the beta-catenin and aurora pathways now in late stage lead candidate optimization. Avalon also has discovery programs on modulators of survivin function and a drug discovery program targeting the MYC oncoprotein, one of the most important and previously intractable c
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
2. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/5/2015)... (Family Features) Which health screenings and exams ... adults, monitoring your weight, cholesterol, and blood pressure is ... about vision care? Photo - ... 40s, they often start to notice small changes in ... job performance. Whether having difficulty reading a book or ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... to announce the chairman of the Summit Mr. Phani ... He will be joined by the expert speaker faculty including ... this May 11 – 12, at The Hotel Kabuki in ... agenda is available for download on the event website, which ...
Breaking Medicine Technology:Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... COLUMBUS, Ohio, June 15, 2011 EndoSphere Inc. ... and international issued and pending patents, announced today that ... company a patent covering the use of its endoscopically ... obesity and type 2 diabetes. U.S. Patent ...
... Corp. (the "Company") (NASDAQ OTC: VSHC) is pleased to be ... fourth quarter of fiscal 2011 to be between $1,050,000 and ... high since inception and represents a substantial increase from previous ... provide further guidance regarding year end revenues for the entire ...
Cached Medicine Technology:EndoSphere Inc. Receives Patent for Obesity Treatment 2Visual Healthcare Provides Fourth Quarter Revenue Guidance 2
(Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
(Date:5/5/2015)... 05, 2015 Information Innovators ... serving the federal government, today announced its acquisition ... CCSi provides solutions exclusively to federal government customers ... in cyber security, health services, and program management ... industry-relevant credentials as a Third Party Assessment Organization ...
(Date:5/5/2015)... On May, 5, 2015, My Positive Perspective host Jason Deierlein ... for youngsters to do this summer. As the episode began, ... starting a summer camp and how is it going to ... Upon a Party and I come to children’s birthday parties ... We play games, sing, and dance and have a great ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 RF Technologies®, ... created the Sensatec® ST750 Fall Management Solution with Voice ... the monitored patient or resident to wait for assistance ... also have the choice of 16 different melodies or ... nurse call system such as Code Alert®. , ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Major League ... with the belief that ultimate Frisbee™ is home to ... next sport that engages the world. Nike Ultimate Camps’ ... by creating opportunities for young athletes to learn about ... with MLU the perfect fit. , The Nike Ultimate ...
Breaking Medicine News(10 mins):Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2
... can deny that this has been a jolly, good year ... University,s Vegetable and Fruit Improvement Center has been named a ... with other scientists and industry. The title of "fellow" ... made exceptional contributions to research and academia. Patil was ...
... single gene programs an immune system helper T cell that ... structure implicated in autoimmune diseases and development of B cell ... Cancer Center reported today in Science Express, the ... The gene is Bcl6, which the team found plays the ...
... , LAS VEGAS, July 23 American Pacific ... wholly-owned subsidiary Ampac Fine Chemicals LLC (AFC) has received from ... a certificate of recognition for "Voluntarily Reducing Pollution." ... EH&S Compliance and Jeff Robinson of AFC, at the Department ...
... , Diverse Donors Make the Difference , ... Day is August 1, and New York Blood Center (NYBC) and its regions ... the community to help us meet the great need for blood from diverse ... Donor Awareness Day emphasized minority organ and tissue donation, but blood donation remains ...
... WASHINGTON, July 23 The Council for American Medical Innovation ... and science policy, as its president. , , ... , Lappin, an attorney, has more than two decades ... organization and serving as a senior advisor to the Directors of both ...
... at the Ohio State University Comprehensive Cancer Center and ... gain the ability to grow without need of hormones. ... and currently incurable stage of prostate cancer. The study, ... journal Cell , focuses on androgen receptors, molecules ...
Cached Medicine News:Health News:Patil: For he's a jolly good science fellow 2Health News:Bcl6 gene sculpts helper T cell to boost antibody production 2Health News:Ampac Fine Chemicals LLC Recognized for Voluntarily Reducing Pollution 2Health News:The Gift of Life Flows Through Your Veins! 2Health News:The Gift of Life Flows Through Your Veins! 3Health News:Council for American Medical Innovation Names Debra R. Lappin President 2Health News:Council for American Medical Innovation Names Debra R. Lappin President 3Health News:Scientists discover key event in prostate cancer progression 2
... Monitoring Station provides alarm and vital ... patients from a single computer workstation. ... and click actions with a computer ... initiate or change monitoring functions from ...
... The reliable and easy-to-use 3800 ... more advancedfeaturing TruTrak+ technology, the proprietary ... These products offer you improved performance:, ... oximeters are submitted to rigorous environmental/ ...
... Station provides an affordable solution that is ... out of the box. Now you can ... rather than transferring patients to high-cost units ... to climb in all areas of the ...
... The reliable and easy-to-use 3800 ... more advancedfeaturing TruTrak+ technology, the proprietary ... These products offer you improved performance:, ... oximeters are submitted to rigorous environmental/ ...
Medicine Products: